Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Porter

Showing results (1371-1380 of 1,461) with videos related to

Pageof 147
Sort By:
ACS Pharmacology & Translational Science|August 25, 2020
Discovery of a First-in-Class Potent Small Molecule Antagonist against the Adrenomedullin-2 ReceptorParis Avgoustou, Ameera B A Jailani, Jean-Olivier Zirimwabagabo, et al.
Elife|June 29, 2016
Functional CRISPR screening identifies the ufmylation pathway as a regulator of SQSTM1/p62Rowena DeJesus, Francesca Moretti, Gregory McAllister, et al.
Nature Biotechnology|May 20, 1999
Production of goats by somatic cell nuclear transferA Baguisi, E Behboodi, D T Melican, et al.
Plos Genetics|November 20, 2020
Rare genetic variation at transcription factor binding sites modulates local DNA methylation profilesAlejandro Martin-Trujillo, Nihir Patel, Felix Richter, et al.
Nature|July 13, 2022
Structure of the MRAS-SHOC2-PP1C phosphatase complexZachary J Hauseman, Michelle Fodor, Anxhela Dhembi, et al.
Chemistry & Biology|September 15, 2015
Metabolic Enzyme Sulfotransferase 1A1 Is the Trigger for N-Benzyl Indole Carbinol Tumor Growth SuppressionDeborah M Rothman, Xiaolin Gao, Elizabeth George, et al.
American Journal of Human Genetics|April 9, 2022
Neither cardiac mitochondrial DNA variation nor copy number contribute to congenital heart disease riskJon A L Willcox, Joshua T Geiger, Sarah U Morton, et al.
Cell|May 3, 2016
Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in HumansTommi Vatanen, Aleksandar D Kostic, Eva d'Hennezel, et al.
Iscience|January 29, 2025
Noncoding variants and sulcal patterns in congenital heart disease: Machine learning to predict functional impactEnrique Mondragon-Estrada, Jane W Newburger, Steven R DePalma, et al.
Nature Communications|December 31, 2024
Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphomaJulia Paczkowska, Ming Tang, Kyle T Wright, et al.
Pageof 147

Showing results (1371-1380 of 1,461) with videos related to

Sort By:
Pageof 147
ACS Pharmacology & Translational Science|August 25, 2020
Discovery of a First-in-Class Potent Small Molecule Antagonist against the Adrenomedullin-2 ReceptorParis Avgoustou, Ameera B A Jailani, Jean-Olivier Zirimwabagabo, et al.
Elife|June 29, 2016
Functional CRISPR screening identifies the ufmylation pathway as a regulator of SQSTM1/p62Rowena DeJesus, Francesca Moretti, Gregory McAllister, et al.
Nature Biotechnology|May 20, 1999
Production of goats by somatic cell nuclear transferA Baguisi, E Behboodi, D T Melican, et al.
Plos Genetics|November 20, 2020
Rare genetic variation at transcription factor binding sites modulates local DNA methylation profilesAlejandro Martin-Trujillo, Nihir Patel, Felix Richter, et al.
Nature|July 13, 2022
Structure of the MRAS-SHOC2-PP1C phosphatase complexZachary J Hauseman, Michelle Fodor, Anxhela Dhembi, et al.
Chemistry & Biology|September 15, 2015
Metabolic Enzyme Sulfotransferase 1A1 Is the Trigger for N-Benzyl Indole Carbinol Tumor Growth SuppressionDeborah M Rothman, Xiaolin Gao, Elizabeth George, et al.
American Journal of Human Genetics|April 9, 2022
Neither cardiac mitochondrial DNA variation nor copy number contribute to congenital heart disease riskJon A L Willcox, Joshua T Geiger, Sarah U Morton, et al.
Cell|May 3, 2016
Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in HumansTommi Vatanen, Aleksandar D Kostic, Eva d'Hennezel, et al.
Iscience|January 29, 2025
Noncoding variants and sulcal patterns in congenital heart disease: Machine learning to predict functional impactEnrique Mondragon-Estrada, Jane W Newburger, Steven R DePalma, et al.
Nature Communications|December 31, 2024
Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphomaJulia Paczkowska, Ming Tang, Kyle T Wright, et al.
Pageof 147